---
document_datetime: 2023-09-21 21:05:41
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/amifampridine-serb-epar-all-authorised-presentations_en.pdf
document_name: amifampridine-serb-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0181317
conversion_datetime: 2025-12-21 11:13:22.501485
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Annex A

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name    | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging    | Pack size                   |
|------------------|--------------------|------------|-----------------------|---------------------------|------------------------|-----------------------------|
| EU/1/22/1646/001 | Amifampridine SERB | 10 mg      | Tablet                | Oral use                  | blister (alu/PVC/PVDC) | 90 x 1 tablets (unit dose)  |
| EU/1/22/1646/002 | Amifampridine SERB | 10 mg      | Tablet                | Oral use                  | blister (alu/PVC/PVDC) | 100 x 1 tablets (unit dose) |
| EU/1/22/1646/003 | Amifampridine SERB | 10 mg      | Tablet                | Oral use                  | blister (alu/PVC/PVDC) | 120 x 1 tablets (unit dose) |